Ansun Biopharma Announces Independent Data Monitoring Committee Recommendation Supporting Continued Phase 3 Development of DAS181 in Immunocompromised Patients with Parainfluenza Infection
PRNewsWire
·
2026-06-01
·
via The Tech Buzz - Press Releases
Committee Recommends Expanding Sample Size After Interim Analysis Places Study in Protocol-Defined Promising…
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。
